- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-3-mer
- Ligands
- 13 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.14: 6 residues within 4Å:- Chain B: K.113, T.114, Q.115, E.132, N.164, N.165
Ligand excluded by PLIPNAG.15: 4 residues within 4Å:- Chain B: G.199, G.232, N.234
- Chain C: H.519
Ligand excluded by PLIPNAG.16: 4 residues within 4Å:- Chain B: N.280, E.281, N.282
- Chain C: K.558
Ligand excluded by PLIPNAG.17: 2 residues within 4Å:- Chain B: N.603, T.604
Ligand excluded by PLIPNAG.18: 3 residues within 4Å:- Chain B: N.616, T.618, E.619
Ligand excluded by PLIPNAG.19: 2 residues within 4Å:- Chain B: Y.655, N.657
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain B: N.709
- Chain D: I.794, Y.796
Ligand excluded by PLIPNAG.21: 6 residues within 4Å:- Chain B: A.706, A.713, E.1072, K.1073, N.1074
- Chain D: Q.895
Ligand excluded by PLIPNAG.22: 5 residues within 4Å:- Chain C: T.108, N.234, T.236
- Chain D: E.465, R.466
Ligand excluded by PLIPNAG.23: 5 residues within 4Å:- Chain C: N.30, F.59, S.60, N.61, W.258
Ligand excluded by PLIPNAG.24: 4 residues within 4Å:- Chain C: N.280, E.281, N.282
- Chain D: K.558
Ligand excluded by PLIPNAG.25: 1 residues within 4Å:- Chain C: N.603
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain C: N.616, E.619, Q.644
Ligand excluded by PLIPNAG.27: 1 residues within 4Å:- Chain C: N.657
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain B: I.794, Y.796
- Chain C: N.709
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain C: A.706, E.1072, N.1074
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain D: G.232, I.233, N.234
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain D: N.61, W.258, T.259
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain D: N.280, E.281, N.282
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain D: N.603, T.604
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain D: N.616, T.618, E.619
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain D: Y.655, V.656, N.657
Ligand excluded by PLIPNAG.36: 4 residues within 4Å:- Chain C: I.794, Y.796
- Chain D: S.708, N.709
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain D: A.706, E.1072, N.1074
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yao, H. et al., A potent and broad-spectrum neutralizing nanobody for SARS-CoV-2 viruses, including all major Omicron strains. MedComm (2020) (2023)
- Release Date
- 2023-12-13
- Peptides
- nanobody Nb4: A
Spike glycoprotein: BCD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
IB
AC
BD
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-3-mer
- Ligands
- 13 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yao, H. et al., A potent and broad-spectrum neutralizing nanobody for SARS-CoV-2 viruses, including all major Omicron strains. MedComm (2020) (2023)
- Release Date
- 2023-12-13
- Peptides
- nanobody Nb4: A
Spike glycoprotein: BCD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
IB
AC
BD
C